Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 125

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD

Kollins, Scott H., Jain, Rakesh, Brams, Matthew, Segal, Scott, Findling, Robert L., Wigal, Sharon B., Khayrallah, Moise · 2011 · Pediatrics

Abstract

OBJECTIVE: To assess the efficacy and safety of clonidine hydrochloride extended-release tablets (CLON-XR) combined with stimulants (ie, methylphenidate or amphetamine) for attention-deficit/hyperactivity disorder (ADHD). PATIENTS AND METHODS: In this phase 3, double-blind, placebo-controlled trial, children and adolescents with hyperactive- or combined-subtype ADHD who had an inadequate response to their stable stimulant regimen were randomized to receive CLON-XR or placebo in combination with their baseline stimulant medication. Predefined efficacy measures evaluated change from baseline to week 5. Safety was assessed by spontaneously reported adverse events, vital signs, electrocardiogram recordings, and clinical laboratory values. Improvement from baseline for all efficacy measures was evaluated using analysis of covariance. RESULTS: Of 198 patients randomized, 102 received CLON-XR plus stimulant and 96 received placebo plus stimulant. At week 5, greater improvement from baseline in ADHD Rating Scale IV (ADHD-RS-IV) total score (95% confidence interval: −7.83 to −1.13; P = .009), ADHD-RS-IV hyperactivity and inattention subscale scores (P = .014 and P = .017, respectively), Conners' Parent Rating Scale scores (P < .062), Clinical Global Impression of Severity (P = .021), Clinical Global Impression of Improvement (P = .006), and Parent Global Assessment (P = .001) was observed in the CLON-XR plus stimulant group versus the placebo plus stimulant group. Adverse events and changes in vital signs in the CLON-XR group were generally mild. CONCLUSIONS: The results of this study suggest that CLON-XR in combination with stimulants is useful in reducing ADHD in children and adolescents with partial response to stimulants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1542/peds.2010-1260

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 15

  1. American Psychiatric Association, 2000, Diagnostic and Statistical Manual of Mental Disorders
  2. Froehlich, 2007, Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children, Arch Pediatr Adolesc Med, 161, 857, 10.1001/archpedi.161.9.857 · DOI · Paper page
  3. Jensen, 1993, Anxiety and depressive disorders in attention deficit disorder with hyperactivity: new findings, Am J Psychiatry, 150, 1203, 10.1176/ajp.150.8.1203 · DOI · Paper page
  4. Newcorn, 2001, Symptom profiles in children with ADHD: effects of comorbidity and gender, J Am Acad Child Adolesc Psychiatry, 40, 137, 10.1097/00004583-200102000-00008 · DOI · Paper page
  5. Barbaresi, 2006, Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study, J Dev Behav Pediatr, 27, 1, 10.1097/00004703-200602000-00001 · DOI
  6. Connor, 2000, A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder, Clin Pediatr (Phila), 39, 15, 10.1177/000992280003900102 · DOI · Paper page
  7. Hunt, 1985, Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial, J Am Acad Child Psychiatry, 24, 617, 10.1016/S0002-7138(09)60065-0 · DOI · Paper page
  8. Agarwal, 2001, Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation, Ment Retard, 39, 259, 10.1352/0047-6765(2001)039<0259:DBPCTO>2.0.CO;2 · DOI
  9. Hazell, 2003, A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children, J Am Acad Child Adolesc Psychiatry, 42, 886, 10.1097/01.CHI.0000046908.27264.00 · DOI · Paper page
  10. Nair, 2009, Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD, J Trop Pediatr, 55, 116, 10.1093/tropej/fmn117 · DOI
  11. Palumbo, 2008, Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes, J Am Acad Child Adolesc Psychiatry, 47, 180, 10.1097/chi.0b013e31815d9af7 · DOI
  12. Schvehla, 1994, Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit, South Med J, 87, 692, 10.1097/00007611-199407000-00004 · DOI
  13. Efron, 2003, Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists, Pediatrics, 111, 372, 10.1542/peds.111.2.372 · DOI
  14. Hazell, 1996, Management of children prescribed psychostimulant medication for attention deficit hyperactivity disorder in the Hunter region of NSW, Med J Aust, 165, 477, 10.5694/j.1326-5377.1996.tb138611.x · DOI
  15. DuPaul, 1998, ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

Cited by

See all 125

Metadata

Authors
Kollins, S. H., Jain, R., Brams, M., Segal, S., Findling, R. L., Wigal, S. B., & Khayrallah, M.
Affiliations
  • Department of Psychiatry, Duke University Medical Center, Durham, North Carolina;
  • Psychiatric Drug Research, R/D Clinical Research Inc, Lake Jackson, Texas;
  • Bayou City Research Ltd, Houston, Texas;
  • Segal Institute for Clinical Research, North Miami, Florida;
  • Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio;
  • Department of Pediatrics, University of California–Irvine, Irvine, California; and
  • Addrenex Pharmaceuticals Inc, a Shionogi Company, Durham, North Carolina
Venue
Pediatrics
Published
2011-06-01
Volume
127
Issue
6
Pages
e1406-e1413
ISSN
  • 0031-4005
  • 1098-4275
Cited by
125
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD. https://app.cochat.ai/papers/10.1542/peds.2010-1260
The paper
Kollins, S. H., Jain, R., Brams, M., Segal, S., Findling, R. L., Wigal, S. B., & Khayrallah, M. (2011). Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD. Pediatrics. https://doi.org/10.1542/peds.2010-1260

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.